CSClara Patricia Setton-Avruj

Clara Patricia Setton-Avruj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Clara Patricia Setton-Avruj has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Vanina Usach

    B Departamento de Química Biológica, Facultad de Farmacia y Bíoquímica , Universidad de Buenos Aires. Instituto de Química y Físicoquímica Biológica (IQUIFIB), UBA-CONICET , Buenos Aires , Argentina

    7 shared publications
  • Gonzalo Piñero

    Departments of Oncological Sciences and Neurosurgery, The Tisch Cancer Institute and

    6 shared publications
  • Paula Andrea Botero Soto

    Instituto de Química y Fisicoquímica Biológica "Alejandro Paladini" UBA-CONICET, Facultad de Farmacia y Bioquímica, Argentina

    5 shared publications
  • Diego Fernando Coral

    Grupo de Ciencia y Tecnología de Materiales Cerámicos (CYTEMAC), Departamento de Física, Universidad del Cauca, Popayán-Colombia

    3 shared publications
  • Paula A. Soto

    Facultad de Farmacia y Bioquímica. Departamento de Química Biológica. Cátedra de Química Biológica Patológica Universidad de Buenos Aires Ciudad Autónoma de Buenos Aires Argentina

    3 shared publications
  • Vanina Usach

    Facultad de Farmacia y Bioquímica. Departamento de Química Biológica. Cátedra de Química Biológica Patológica Universidad de Buenos Aires Ciudad Autónoma de Buenos Aires Argentina

    3 shared publications

Latest Publications

  • Open Access

    Schwann Cells in Development, Regeneration, and Therapeutic Applications: Insights From the Sciatic Nerve Model

    by Vanina Usach, Paula A. Soto, C. Patricia Setton‐Avruj

    The sciatic nerve is the largest nerve in the human body and is frequently affected by lesions, causing pain and even loss of sensitivity. The sciatic nerve injury model provides a robust platform to study the degeneration‐regeneration process. In this context, Schwann cells (SC) are central regulators of peripheral nervous system (PNS) development, homeostasis, and regeneration. During development, SC arise from neural crest–derived precursors and undergo tightly regulated lineage progression, culminating in myelinating and non‐myelinating phenotypes. This process is orchestrated by coordinated transcriptional, signaling, and epigenetic mechanisms that control radial sorting, differentiation, and myelination. Following nerve injury, SC exhibit remarkable plasticity, reprogramming into a specialized repair phenotype that promotes axonal regeneration through debris clearance, trophic support, immune modulation, and the formation of Büngner bands. This work aims to summarize the known history of the plasticity and functions of SC during nerve development and regeneration. It also aims to highlight the most recent advances regarding the molecular networks underlying SC plasticity, as well as epigenetic regulators that enable dynamic transitions between cellular states. This work also describes the factors compromising nerve regeneration and functional recovery, and summarizes the emerging therapeutic strategies aimed to overcome these limitations by enhancing SC plasticity, modulating the injury microenvironment, and developing alternative cell sources, including stem cell–derived Schwann‐like cells. A deeper understanding of SC heterogeneity, lineage dynamics, and regenerative mechanisms will be essential for advancing translational strategies. Collectively, this review underscores the pivotal role of SC in nerve regeneration and highlights innovative approaches to harness their therapeutic potential. image


  • Open Access

    Late Bone Marrow Mononuclear Cell Transplantation in Rats with Sciatic Nerve Crush: Analysis of a Potential Therapeutic Time Window

    by Vanina Usach, Mailin Casadei, Gonzalo Piñero, Marianela Vence, Paula Soto, Alicia Cueto, Pablo Rodolfo Brumovsky, Clara Patricia Setton-Avruj

    After peripheral nerve injury, axon and myelin regeneration are key events for optimal clinical improvements. We have previously shown that early bone marrow mononuclear cell (BMMC) transplantation exerts beneficial effects on myelin regeneration. In the present study, we analyze whether there is a temporal window in which BMMCs migrate more efficiently to damaged nerves while still retaining their positive effects. Adult Wistar rats of both sexes, with sciatic nerve crush, were systemically transplanted with BMMC at different days post injury. Vehicle-treated, naïve, and sham rats were also included. Morphological, functional, and behavioral analyses were performed in nerves from each experimental group at different survival times. BMMC transplantation between 0 and 7 days after injury resulted in the largest number of nested cells within the injured sciatic nerve, which supports the therapeutic value of BMMC administration within the first week after injury. Most importantly, later BMMC administration 7 days after sciatic nerve crush was associated with neuropathic pain reversion, improved morphological appearance of the damaged nerves, and a tendency toward faster recovery in the sciatic functional index and electrophysiological parameters. Our results thus support the notion that even delayed BMMC treatment may represent a promising therapeutic strategy for peripheral nerve injuries.


  • Open Access

    Late Bone Marrow Mononuclear Cell Transplantation in Rats with Sciatic Nerve Crush. Analysis of a Potential Therapeutic Time Window.

    by Vanina Usach, Mailin Casadei, Gonzalo Piñero, Marianela Vence, Paula Soto, Alicia Cueto, Pablo Brumovsky, Clara Patricia Setton-Avruj

    After peripheral nerve injury, axon and myelin regeneration are key events for optimal clinical improvements. We have previously shown that early bone marrow mononuclear cell (BMMC) transplantation exerts beneficial effects on myelin regeneration. In the present study we analyze whether there is a temporal window in which BMMC migrate more efficiently to damaged nerves while still retaining their positive effects. Adult Wistar rats of both sexes, with sciatic nerve crush were systemically transplanted with BMMC at different days post injury. Vehicle-treated, naïve, and sham rats were also included. Morphological, functional, and behavioral analyses were performed in nerves from each experimental group at different survival times. BMMC transplantation between 0 and 7 days after injury resulted in the largest number of nested cells within the injured sciatic nerve, which supports the therapeutic value of BMMC administration within the first week after injury. Most importantly, later BMMC administration 7 days after sciatic nerve crush was associated with neuropathic pain reversion, improved morphological appearance of the damaged nerves, and a tendency toward faster recovery in the sciatic functional index and electrophysiological parameters. Our results thus support the notion that even delayed BMMC treatment may represent a promising therapeutic strategy for peripheral nerve injuries.


  • Open Access

    All the PNS is a Stage: Transplanted Bone Marrow Cells Play an Immunomodulatory Role in Peripheral Nerve Regeneration

    by Gonzalo Piñero, Marianela Vence, Marcos L. Aranda, Magalí C. Cercato, Paula A. Soto, Vanina Usach, Patricia C. Setton-Avruj

    Bone marrow cell transplant has proven to be an effective therapeutic approach to treat peripheral nervous system injuries as it not only promoted regeneration and remyelination of the injured nerve but also had a potent effect on neuropathic pain.


  • Open Access

    The best of both worlds: mastering nerve regeneration combining biological and nanotechnological tools

    by Paula A. Soto, Marcela B. Fernández van Raap, C. Patricia Setton-Avruj


  • Small-angle X-ray scattering to quantify the incorporation and analyze the disposition of magnetic nanoparticles inside cells

    by D.F. Coral, P.A. Soto, E. de Sousa, M.E.F. Brollo, J.A Mera-Córdoba, P. Mendoza Zélis, C.P. Setton-Avruj, A. Roig, M.B. Fernández van Raap


  • Sciatic nerve regeneration after traumatic injury using magnetic targeted adipose-derived mesenchymal stem cells

    by Paula A. Soto, Marianela Vence, Gonzalo M. Piñero, Diego F. Coral, Vanina Usach, Diego Muraca, Alicia Cueto, Anna Roig, Marcela B. Fernández van Raap, Clara P. Setton-Avruj


  • Open Access

    Busting the myth: more good than harm in transgenic cells

    by Gonzalo Piñero, Patricia Setton-Avruj

  • Metal bashing: iron deficiency and manganese overexposure impact on peripheral nerves

    by Robyn M. Amos-Kroohs, Vanina Usach, Gonzalo Piñero, Charles V. Vorhees, Rocío Martinez Vivot, Paula A. Soto, Michael T. Williams, Patricia Setton-Avruj

    Iron (Fe) deficiency (FeD) and manganese (Mn) overexposure (MnOE) may result in several neurological alterations in the nervous system. Iron deficiency produces unique neurological deficits due to its elemental role in central nervous system (CNS) development and myelination, which might persist after normalization of Fe in the diet. Conversely, MnOE is associated with diverse neurocognitive deficits. Despite these well-known neurotoxic effects on the CNS, the influence of FeD and MnOE on the peripheral nervous system (PNS) remains poorly understood. The aim of the present investigation was to examine the effects of developmental FeD and MnOE or their combination on the sciatic nerve of young and adult rats. The parameters measured included divalent metal transporter 1 (DMT1), transferrin receptor (TfR), myelin basic protein (MBP) and peripheral myelin protein 22 (PMP22) expression, as well as Fe levels in the nerve. Our results showed that FeD produced a significant reduction in MBP and PMP22 content at P29, which persisted at P60 after Fe-sufficient diet replenishment regardless of Mn exposure levels. At P60 MnOE significantly increased sciatic nerve Fe content and DMT1 expression. However, the combination of FeD and MnOE produced no marked motor skill impairment. Evidence indicates that FeD appears to hinder developmental peripheral myelination, while MnOE may directly alter Fe homeostasis. Further studies are required to elucidate the interplay between these pathological conditions.


  • Nanoclusters of crystallographically aligned nanoparticles for magnetic thermotherapy: aqueous ferrofluid, agarose phantoms andex vivomelanoma tumour assessment

    by D. F. Coral, P. A. Soto, V. Blank, A. Veiga, E. Spinelli, S. Gonzalez, G. P. Saracco, M. A. Bab, D. Muraca, P. C. Setton-Avruj, et al.

    Magnetic hyperthermia is an oncological therapy where magnetic nanostructures, under a radiofrequency field, act as heat transducers increasing tumour temperature and killing cancerous cells. Nanostructure heating efficiency depends both on the field conditions and on the nanostructure properties and mobility inside the tumour. Such nanostructures are often incorrectly bench-marketed in the colloidal state and using field settings far off from the recommended therapeutic values. Here, we prepared nanoclusters composed of iron oxide magnetite nanoparticles crystallographically aligned and their specific absorption rate (SAR) values were calorimetrically determined in physiological fluids, agarose-gel-phantoms and ex vivo tumours extracted from mice challenged with B16-F0 melanoma cells. A portable, multipurpose applicator using medical field settings; 100 kHz and 9.3 kA m−1, was developed and the results were fully analysed in terms of nanoclusters’ structural and magnetic properties. A careful evaluation of the nanoclusters’ heating capacity in the three milieus clearly indicates that the SAR values of fluid suspensions or agarose-gel-phantoms are not adequate to predict the real tissue temperature increase or the dosage needed to heat a tumour. Our results show that besides nanostructure mobility, perfusion and local thermoregulation, the nanostructure distribution inside the tumour plays a key role in effective heating. A suppression of the magnetic material effective heating efficiency appears in tumour tissue. In fact, dosage had to be increased considerably, from the SAR values predicted from fluid or agarose, to achieve the desired temperature increase. These results represent an important contribution towards the design of more efficient nanostructures and towards the clinical translation of hyperthermia.